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 Herniated nucleus pulposus (HNP) is one of peripheral neuropathic pain. 
Although concensus guidelines for the treatment of neuropathic pain are 
based on the results of the RCT studies, there are still gaps in the literatures. 
This study aimed to compare the effectiveness and quality of life of 
gabapentin and amitriptyline for the treatment of pain in HNP. The method 
used a quasi experimental with consequtive sampling. This study included 30 
patients in the gabapentin group and 26 patients in the amitriptyline group, 
and each group was evaluated for 1 month.  Effectiveness was assessed using 
Visual Analogue Scale (VAS) every 2 weeks then analized by Mann 
Whitney test. The results showed that the use of gabapentin and amitriptilin 
in 4 weeks showed the decrease of pain score measured by visual analog 
scale 3.70 ± 0.349 and 3.500 ± 0.34 although there was no statistical 
difference (p value = 0.704). To sum up, effectiveness of gabapentin and 
amitriptyline in the treatment of neuropathic pain did not have statistical 
difference.
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1. INTRODUCTION  
There are two kinds of pain namely nosiseptic and neurophatic [1]. Neurophatic is a sensoric and 
emotional experience that is unpleasant and has significant influence toward a person’s living quality [2]. 
Neurophatic pain has similar characteristic to the other cronical pains which influence significantly toward 
psychological, social function, and the other health aspects correlated to living quality of the people [3].  
Neurophatic pain usually has not good response toward analgesic standard by World Health 
Organization (WHO), like non-steroid anti-inflamation medicine (NSAID) and opioid [4]. NSAID and 
asetaminofen are not effective toward neurophatic pain [1]. 
Antidepressant and antiepilepcy medicine become the first line of the medicine to overcome 
neurophatic pain [5]. Antidepressant has been proven to bring benefit in diabetes neurophatic, with the best 
effect can be reached by tricyclic antidepressant (TCA) [6]. Amitriptilin becomes one main choice for 
neurophatic pain from the group of tricyclic antidepressant [2]. Antiepilepcy medicine has shown its efficacy 
toward some types of neurophatic pain. Gabapentin has been approved by Food and Drug Administration 
(FDA) as an additional theraphy for partial epilepcy and management postherpetic neuralgia [7].  
Gabapentin is included in the list of medicine plavon price (Daftar Plavon Harga Obat-DPHO)  of 
health insurance in 2013 for the diagnose of postherphetic neuralgia (PHN) [8]. It is based on various 
evidences and researches which support gabapentin as a theraphy choice in PHN. Meanwhile, amitriptilin can 
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generally be included in DPHO as one of the theraphies for some related diseases. By considering that there 
is not enough literature proving the effectivity of gabapentin as HNP theraphy, gabapentin as HNP theraphy 
has not been included in the plavon of health insurance DPHO.  
Pheriphenal neurophaty pain is one of the causes of neurophaty pain [2]. Herniated nucleus pulposus 
(HNP) or known by slipped neuron disease is one kind of pheriphenal neurophaty pain. Most of the 
researches nowadays only focus on postherpetic neuralgia or diabetic peripheral neuropathy, but in this study 
the researcher focuses on patients with neurophaty pain having lesion or other diseases as painful cause 
including herniated nucleus pulposus. 
 
 
2. RESEARCH METHOD  
 
2.1. Materials  
Tools and materials needed for this study were informed consents used to ask patients’ willingness 
to be the subjects of the study. Besides, the researcher also used questioners to examine demographic data of 
the patients as well as to measure the effectivity between gabapentin and amitriptilin with Visual Analog 
Scale (VAS).  
Visual Analog Scale is a measurement scale that is often used to measure pain intencity in the 
clinical test [9]. The score of VAS 0-<4 can be categorized as light pain, 4-<7 is medium pain, and 7-10 is 
heavy pain [10]. The study used VAS as a scale measurement for pain intencity herniated nucleus pulposus 
patients with the measurement interval 2 weeks with monitoring time 1 month, so there would be available 
data for pain score with VAS scale in week 0, week 2 and week 4.  
 
2.2. Research Process 
The research was conducted by measuring the effectivity gabapentin with the dose 100 mg 2 times a 
day or amitriptilin 12.5 mg once in a day. Effectivity monitoring was done every one time in two weeks 
during 1 month treatment by regarding the score of VAS. This study was conducted in Jogja Hospital. Every 
patient was given one of the drugs (gabapentin or amitriptyline) and given a referral to physiotherapy. 
Physiotherapy was done 3 times a week for 2 weeks followed by twice a week for the next 2 weeks. In 
addition the patients were also asked to use the corset that had been provided. Patients not allowed to use the 
pain medication during the study. It aims to give the standart therapy for HNP and give equal treatment to all 
patient. The data was processed and analyzed by using Mann Whitney test to compare the effectivity from 
gabapentin and amitriptilin. On the other hand, descriptive analysis was used to describe socio-demographic 
factor, pain characteristic from the patients. 
 
 
3. RESULTS AND DISCUSSION 
  
3.1. Respondents’ Characteristic 
Complete data that could be analyzed were 56 respondents, in which 30 respondents were from the 
group taking gabapentin, and 26 respondents were from the group taking amitriptilin. Respondents’ 
description can be seen from 4 characteristics such as age, gender, education background, and occupation. 
The data above can be explained in Table 1. 
Table 1 shows that the respondents were grouped into several categories such as age, gender, 
education background, and occupation. Based on statistical analysis using chi square test got the result 
respectively 0.556; 0.920; 0.601; 0.167. It shows that there was no significant difference in every 
characteritis of the research subject, so it could be concluded that the subjects of the research were 
homogenous. 
Based on the interview, responden experienced very disturbing pain in several days before having 
consultation to the hospital. Most of the patients said that they had pain before because of one thing such as 
lifting heavy load, falling down, or activities with high intencity. Here they are pain characteristic of the 
patients that is shown in Table 2. 
Table 2 shows that the main respondents’ pain characteristics were to beat feeling that could be felt 
by 39 respondents (69.64%). Sharp pain was felt by 33 respondents (58.93%), burnt feeling could be felt by 
20 respondents (35.71%), and cramp could be felt by 21 respondents (37.50%), while biting feeling could be 
felt by 18 respondents (32.14%). HNP is one kind of neurotropic pain. The distinctive characteristic from 
neurotropic pain was sensations like being bitten, getting electrical shock, burnt, stiff, and numb. Patients 
usually felt the symtoms of allodynia (pain that is caused by the stimulus that does not cause any pain like 
touching) and hyperalgesia (increase respons toward stimulus that is usually hurt) [2]. 
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Table 1. Demographic Characteristic of the Research Subjects 
Respondents’ Characteristic Gabapentin Amitriptilin Respondent Total Amount Percentage (%) Amount Percentage (%) Amount Percentage (%) 
Age 21-30 year old - - 1 3.85 1 1.79 
31-40 year old - - 1 3.85 1 1.79 
41-50 year old 4 13.33 4 15.38 8 14.29 
51-60 year old 10 33.33 11 42.31 21 37.50 
61-70 year old 11 36.67 7 26.92 18 32.14 
71-80 year old 5 16.67 2 7.69 7 12.50 
Total 30 100.00 26 100.00 56 100.00 
Gender Male 10 33.33 9 34.62 29 51.79 
Female 20 66.67 17 65.38 27 48.21 
Total 30 100.00 26 100.00 56 100.00 
Education 
Background 
No School - - 1 3.85 1 1.79 
SD 4 13.33 6 23.08 10 17.86 
SMP 6 20.00 5 19.23 11 19.64 
SMU 9 30.00 8 30.77 17 30.36 
University 11 36.67 6 23.08 17 30.36 
Total 30 100.00 26 100.00 56 100.00 
Occupation Unemploymnt - - 1 3.85 1 1.79 
Civil Servant 4 13.33 4 15.38 8 14.29 
Private Sector 1 3.33 3 11.54 4 7.14 
Enterpreneur 8 26.67 1 385 9 16.07 
House Wife 7 23.33 11 42.31 18 32.14 
Labour 2 6.67 2 7.69 4 7.14 
Retired 8 26.67 4 15.38 12 21.43 
Total 30 100.00 26 100.00 56 100.00 
 
 
Table 2. The Characteristic of Respondents’ Pain 
Pain Characteristics The Number of Respondents Percentage (%) 
Beating 39 69.64 
Sharp 33 58.93 
Burnt 20 35.71 
Cramp 21 37.50 
Biting  18 32.14 
 
Pain location felt by the patients was also various; they were in the back bone, leg, and tigh. Pain 
location of the respondents is showed in Table 3. Table 3 shows that 34 respondents (60.71%) experienced 
the pain in the back bone and leg. Respondents who experienced the pain only in the back were 13 
respondents (23.21%).  There were 8 respondents (14.29%) who experienced the pain only in the leg, and 1 
respondent (1.79%) experienced the pain in the back bone and tigh. 
 
Table 3. Respondents’ Pain Location 
Pain Location The Number of the Respondents Percentage (%) 
Back bone and leg 34 60.71 
Back bone 13 23.21 
Leg  8 14.29 
Back bone until tigh 1 1.79 
Total 56 100.00 
 
 
The pain of nosiseptic experienced by the patients could easily explain the pain location exactly, but 
the patients with neurotropic pain sometimes get difficulties to mention the location of the pain exactly 
because neurotropic pain is sometimes wider [1]. HNP pain with the source of the back bone often spreads to 
the leg or to the reproduction organ because of the existence of cauda equine, a group of neuron connecting 
and providing the communication with low extremity and duodenum control, urether, and sexual function 
[11]. In an extreme condition, discus experiencing herniation is able to press the edge of the neuron in cauda 
equine which causes cauda equine syndrome causing bilateral pain in the leg, both legs paralyze, and 
disability to hold the pee [12]. 
 
3.2. The Analisys of Visual Analog Scale (VAS) 
Initial measurement to the score of pain intencity using VAS can be done when the patients fulfill 
incoming inclusion criteria to receive the medicine and conducting interview. The patients were asked to 
assess their pain intencity with VAS scale. The result of the research shows that the initial measurement 
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(week 0) patients in the group of gabapentin 93% had heavy pain and 7% medium pain, while in the group of 
amitriptilin 80.7% had heavy pain and 19.3% medium pain. The result of the research was similar to a 
research conducted by Ohtori et. al. (2013) mentioning that the patients with herniated nucleus pulposus 
diagnose usually had pain intencity measured with VAS scale around 5-9 [13]. 
The patients given gabapentin theraphy in this research were 30. Regiment of the dose based on 
guideline NICE (2010) mentions that for the theraphy of neurophaty pain, the dose of gabapentin adviced is 
100-300 mg before sleeping or 100-300 mg in a day [2]. However, the dose used in this research was 100 mg 
2x in a day. It was done because in the previous study with the dose of 300 mg in a day, most of the patients 
complained of its side effect that made them feeling weak and disturbed, so they were not able to tolerate that 
condition. 
The patients who got amitriptilin theraphy were 26. Amitriptilin dose given was 12.5 mg in the 
evening. The regiment of this dose is based on NICE (2010) mentioning that the dose of amitriptilin for the 
theraphy of neuropathic pain was 10-75 mg once a day [2]. 
Based on the normality test, it got the information that the data from the value of visual analog scale 
(VAS) was completely distributed with p value> 0.05 both for gabapentin group and for amitriptilin group. It 
indicates that it can be analyzed by using paired sample t test. The result of this test is presented in Table 4. 
 
 
Table 4. The Comparison of Score Decrease of VAS in Gabapentin and  Amitriptilin Group 
VAS Measurement Treatment Group N Mean Score of Declining VAS p value 
Week 0 to week 2 gabapentin 30 1.967±0.211 0.340 amitriptilin 26 1.731±0.219  
Week 0 to week 4 gabapentin 30 3.700±0.349 0.704 
amitriptilin 26 3.500±0.343  
 
 
Based on Table 4 can be known that the result of VAS score decrease in week 2 and week 4 did not 
have significant different of the effectivity of gabapentin group and amitriptilin group. It can be shown from 
p value which was more than 0.05. 
The result of the research is similar to a research conducted by Morello dkk (1999) showing that 
there was no significant difference between gabapentin and amitriptilin group in its effectivity for painful 
with diabetes mellitus (PDN) [6]. A research done by Dallocchio dkk (2000) showed higher pain decrease 
than the patients with gabapentin treatment, but it was not different statistically [14]. Another research 
conducted by Vega (2010) explains the comparison of amitriptilin effectivity and pregabalin effectivity in the 
theraphy of painful diabetic neuropathy [15]. Pregabalin is an anticonvulsant which also becomes one of the 
first line theraphies for neurophatic pain which has action mechanism like gabapentin [2]. The result of the 
research shows that there was no significant difference in decreasing the pain. 
The result of this research also shows that both gabapentin group and amitriptilin group show pain 
decrease if it was compared before and after the theraphy. Statistically it shows significant difference with p 
value 0.000 (p<0.05). This result indicates that amitriptilin and gabapentin are effective as pain killer 
theraphy in herniated nucleus pulposus. The result of the analysis is presented in Table 5. 
 
 
Table 5. Comparison Analysis Result of VAS Score by Giving Gabapentin and Amiriptilin 
Information Gabapentin Amitriptilin 
Mean ±  SE week 0 8.733± 0,262 8.346± 0.337 
Mean ±  SE week 4 5.033± 0,360 4.846± 0.406 
p value 0.000 0.000 
 
 
This result is similar to some researches related to both gabapentin effectivity and amitriptilin 
eefctivity to neurophatic pain such as Backonja et. al. (1998) conducting a research to the patients with 
Painful Neuropathy in Patients with Diabetes Mellitus diagnose [16]. VAS value from the patients getting 
gabapentin theraphy had decrease from 6.4 becoming 3.8 after 8 weks, compared to placebo group from 6.5 
becoming 5.1 with p value<0.001. 
 
3.3. Side Effect 
Side effect becomes one of the parameters which need to be considered in choosing a particular 
theraphy. Side effect does not always appear in every patient, but it should become an alert so that the 
patients can anticipate it. The existence of its efefctivity evidence of the medicine for the theraphy of 
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neurophatic pain is significantly needed to health staffs to determine the most effective medicine in reducing 
pain and having minimal adverse effect. Ideally, the evidence of choosing medicine in a particular algorithm 
is based on its direct comparison one medicine with the others, both its efficacy and its side effect [17]. 
In this research, most of the patients did not experience significant side effect. Only several people 
got its side effect, but it was still able to be tolerated, so they were atill able to follow thetheraphy session. 
However, there were some patients dropping out because they could not tolerate the incoming side effect. It 
happened from both gabapentin group and amitriptilin group. One of the patients complained disturbing 
fatigue after consuming amitriptilin, besides there was sedation effect that disturbed the patients’ daily 
activities, so they could not continue to participate in the research. In gabapentin group, there were some 
patients complaining to have stiff feeling after consuming gabapentin, so the patients determined to drop out. 
The side effect of the medicine both in gabapentin group and in amitriptilin group is presented in Table 6. 
 
 
Table 6. Side Effect in the Patients Having Theraphy with Gabapentin and Amitriptilin 
Side Effect Gabapentin Amitriptilin 
Sedative  9 
Dry mouth 1 1 
Neusea 3  
Headache  1 
Tired 1 1 
Total  5 12 
 
 
Based on Table 6, it is known that the stage of side effect coming to the group of amitriptilin was 
sedation with 30 %, dry mouth, headache, and tiredness respectively 3.3% from 30 patients. While 31 
patients got gabapentin theraphy 3.2% reported dry mouth, 3.2% tiredness 9.7% feeling nauseated. This side 
effect is similar to the previous researches related to the use of gabapentin and amitriptilin. 
Side effect of amitriptilin was mostly reported by some researches such as a research conducted by 
Vega (2010) mentioning that the patients with painful diabetic neuropathy got some side effects like 
sleepiness 43% for amitriptilin and 20% to the patients with pregabalin. A research result by Kaur, et. al. 
(2011) also explains that the use of amitriptilin shows the most often side effect like dry mouth (28.8%) with 
p value< 0,001 and sleepiness 18.9% from 111 occurences, the side effect reported was 58 patients taking 
part to the research [18]. Adverse effect from amitriptilin can appear toward cardiovascular system like 
postural hypotension, takikardi; central neuron system like anxiety, headache, extrapirimidal symptoms, 
insomnia, sedation and skin effect like photosensitive, alergi, urtikaria, digestion system  like constipation, 
increasing weight and low vision, midriasis [19].  
A research conducted by Rintala et al (2007) compared the use of amitritptilin and gabapentin as 
pain theraphy in spinal cord injury, the patients reported tthat the side effect of using amitriptilin was dry 
mouth (63.8%), sleepiness (27.1%), and constipation (29.2%), tiredness (20.5%) [20]. A similar theory was 
also reported by the patients who got gabapentin theraphy with the same occurrence stage.  
Adverse effect from gabapentin can appear such as sedative, dry mouth, headache, postural 
hipotension, ataxia, constipation, letargi, edema, pruritis, incomfortable feeling, diarhea, nausea, unclear 
vision, and the others [6]. According to Morello, it is also explained that the use of amitriptilin in neurophaty 
pain theraphy, the side effect that is mostly experienced by the patients are sedative and dry mouth that can 
be worse from time to time. Meanwhile, in the use of gabapentin the side effect reported was sedative and 
headache. The other side effects experienced by the patients are postural hypotension, weight increase, ataxia 
and letargi although it appears in low prevalence. 
Based on the discussion above, it can be concluded that the side effect of gabapentin and amitriptilin 
is basically similar, but in this research sedative side effect mostly could be found by the patients getting 
amitriptilin theraphy, while gabapentin did not report more side effect reported by the respondents. It is 
possible because the effect of antidepressant from the amitriptilin was bigger, so it had more effect to calm 
down or sedative. The side effect cannot be separated from the medicine and individual condition of the 
patients. The treatment can decrease pain intencity of the patients, and it is closely correlated to the increase 
of living quality, but it did not decrease its side effect [21]. 
 
 
4. CONCLUSION  
The use of gabapentin and amitriptilin in 4 weeks showed the decrease of pain score measured by 
visual analog scale 3.70 ± 0.349 and 3.500 ± 0.343 with p value> 0.05 which means that it was not 
significantly different, Reported side effect from the use of gabapentin was 3.2% feeling dry mouth, 9.7% 
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feeling nausea and 3.2% feeling tiredness; while for the use of amitriptilin was sedative 30% , dry mouth, 
headache and tiredness respectively 3.3%. 
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